TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gastric Cancer
Related studies linked through entity extraction aliases.
A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study
- Status
- COMPLETED
- Phase
- PHASE2
HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis
- Status
- UNKNOWN
- Phase
- PHASE2
Body Composition After Laparoscopic Gastrectomy for Gastric Cancer
- Status
- COMPLETED
- Phase
- NA
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
- Status
- COMPLETED
- Phase
- N/A
Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
- Status
- WITHDRAWN
- Phase
- PHASE3
Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment
- Status
- UNKNOWN
- Phase
- PHASE2